Efficacy and safety of intravenous and oral nadolol for supraventricular tachycardia in children.

Author: ChidambaramB, MehtaA V

Paper Details 
Original Abstract of the Article :
The efficacy and safety of oral nadolol in supraventricular tachycardia were evaluated prospectively in 27 children (median age 5.5 years). Fifteen patients had an unsuccessful trial of digoxin therapy. Intravenous nadolol was given to seven patients during electrophysiologic study; five of these ha...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/s0735-1097(10)80283-9

データ提供:米国国立医学図書館(NLM)

Nadolol: A Powerful Ally Against Supraventricular Tachycardia in Children

Imagine a camel caravan with a young foal struggling to keep up, its heart racing with every step. This is a bit like what a child with supraventricular tachycardia (SVT) experiences, a condition where the heart beats too fast. This study explores the effectiveness of nadolol, a beta blocker, in treating SVT in children.

The researchers studied 27 children with SVT, using both intravenous and oral forms of nadolol to control the heart rate. They compared the results to other medications like digoxin and propranolol, like a camel caravan experimenting with different strategies to find the best solution for their young foal. They found that nadolol was safe and effective in managing SVT, with a long-term effect that could be predicted by the short-term response.

This study provides valuable information for clinicians managing SVT in children, offering a reliable and effective treatment option. It's like a camel caravan finding a dependable oasis, offering respite and rejuvenation on their long journey.

A Strong Heartbeat: Nadolol's Success in Treating SVT

This research demonstrates the safety and effectiveness of nadolol in treating SVT in children, offering a valuable tool for clinicians to manage this condition. It's like discovering a reliable source of water in the desert, a source of strength and resilience for the camel caravan.

Navigating the Heart: Finding the Right Treatment for Children with SVT

For families navigating the challenges of SVT in their children, this research offers a beacon of hope. Nadolol can be a safe and effective treatment option, helping to manage the condition and improve the child's quality of life. It's like finding a trusted guide to help navigate the complex terrain of childhood heart health, offering reassurance and support along the way.

Dr. Camel's Conclusion

This study demonstrates the safety and effectiveness of nadolol in treating SVT in children, offering a valuable tool for clinicians to manage this condition.

Date :
  1. Date Completed 1992-03-31
  2. Date Revised 2019-07-08
Further Info :

Pubmed ID

1538020

DOI: Digital Object Identifier

10.1016/s0735-1097(10)80283-9

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.